128 related articles for article (PubMed ID: 32858102)
21. [Clinical function of estrogen receptors in endometrial cancer].
Caringella AM; Di Naro E; Loverro G
Minerva Ginecol; 2011 Dec; 63(6):495-504. PubMed ID: 22036754
[TBL] [Abstract][Full Text] [Related]
22. Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer.
Singhal H; Greene ME; Tarulli G; Zarnke AL; Bourgo RJ; Laine M; Chang YF; Ma S; Dembo AG; Raj GV; Hickey TE; Tilley WD; Greene GL
Sci Adv; 2016 Jun; 2(6):e1501924. PubMed ID: 27386569
[TBL] [Abstract][Full Text] [Related]
23. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
[TBL] [Abstract][Full Text] [Related]
24. MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells.
Bhattacharya A; Fushimi A; Yamashita N; Hagiwara M; Morimoto Y; Rajabi H; Long MD; Abdulla M; Ahmad R; Street K; Liu S; Liu T; Kufe D
Mol Cancer Res; 2022 Apr; 20(4):556-567. PubMed ID: 35022313
[TBL] [Abstract][Full Text] [Related]
25. ARID1A loss in cancer: Towards a mechanistic understanding.
Mathur R
Pharmacol Ther; 2018 Oct; 190():15-23. PubMed ID: 29730444
[TBL] [Abstract][Full Text] [Related]
26. ASH2L is involved in promotion of endometrial cancer progression via upregulation of PAX2 transcription.
Zeng K; Wu Y; Wang C; Wang S; Sun H; Zou R; Sun G; Song H; Liu W; Sun N; Wei S; Liu W; Su Y; Zhou T; Zhang Y; Zhao Y
Cancer Sci; 2020 Jun; 111(6):2062-2077. PubMed ID: 32279431
[TBL] [Abstract][Full Text] [Related]
27. The basic helix-loop-helix-PAS protein ARNT functions as a potent coactivator of estrogen receptor-dependent transcription.
Brunnberg S; Pettersson K; Rydin E; Matthews J; Hanberg A; Pongratz I
Proc Natl Acad Sci U S A; 2003 May; 100(11):6517-22. PubMed ID: 12754377
[TBL] [Abstract][Full Text] [Related]
28. ARID1A spatially partitions interphase chromosomes.
Wu S; Fatkhutdinov N; Rosin L; Luppino JM; Iwasaki O; Tanizawa H; Tang HY; Kossenkov AV; Gardini A; Noma KI; Speicher DW; Joyce EF; Zhang R
Sci Adv; 2019 May; 5(5):eaaw5294. PubMed ID: 31131328
[TBL] [Abstract][Full Text] [Related]
29. ARID1A gene mutation in ovarian and endometrial cancers (Review).
Takeda T; Banno K; Okawa R; Yanokura M; Iijima M; Irie-Kunitomi H; Nakamura K; Iida M; Adachi M; Umene K; Nogami Y; Masuda K; Kobayashi Y; Tominaga E; Aoki D
Oncol Rep; 2016 Feb; 35(2):607-13. PubMed ID: 26572704
[TBL] [Abstract][Full Text] [Related]
30. Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma.
Yen TT; Miyamoto T; Asaka S; Chui MH; Wang Y; Lin SF; Stone RL; Fader AN; Asaka R; Kashima H; Shiozawa T; Wang TL; Shih IM; Tanner EJ
Gynecol Oncol; 2018 Sep; 150(3):426-431. PubMed ID: 30126589
[TBL] [Abstract][Full Text] [Related]
31. Estrogen and growth factor signaling pathway: basic approaches for clinical application.
Hayashi S; Sakamoto T; Inoue A; Yoshida N; Omoto Y; Yamaguchi Y
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):433-42. PubMed ID: 14623541
[TBL] [Abstract][Full Text] [Related]
32. The SWI/SNF chromatin remodeling subunit BAF57 is a critical regulator of estrogen receptor function in breast cancer cells.
García-Pedrero JM; Kiskinis E; Parker MG; Belandia B
J Biol Chem; 2006 Aug; 281(32):22656-64. PubMed ID: 16769725
[TBL] [Abstract][Full Text] [Related]
33. CTCF modulates Estrogen Receptor function through specific chromatin and nuclear matrix interactions.
Fiorito E; Sharma Y; Gilfillan S; Wang S; Singh SK; Satheesh SV; Katika MR; Urbanucci A; Thiede B; Mills IG; Hurtado A
Nucleic Acids Res; 2016 Dec; 44(22):10588-10602. PubMed ID: 27638884
[TBL] [Abstract][Full Text] [Related]
34. 17 beta-estradiol activates PI3K/Akt signaling pathway by estrogen receptor (ER)-dependent and ER-independent mechanisms in endometrial cancer cells.
Guo RX; Wei LH; Tu Z; Sun PM; Wang JL; Zhao D; Li XP; Tang JM
J Steroid Biochem Mol Biol; 2006 Apr; 99(1):9-18. PubMed ID: 16567092
[TBL] [Abstract][Full Text] [Related]
35. The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium.
Heckl M; Schmoeckel E; Hertlein L; Rottmann M; Jeschke U; Mayr D
PLoS One; 2018; 13(2):e0192881. PubMed ID: 29451900
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of estrogen receptor by the methylation of the estrogen receptor gene in endometrial carcinoma.
Shiozawa T; Itoh K; Horiuchi A; Konishi I; Fujii S; Nikaido T
Anticancer Res; 2002; 22(1A):139-43. PubMed ID: 12017277
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanism of WW-domain binding protein-2 coactivation function in estrogen receptor signaling.
Buffa L; Saeed AM; Nawaz Z
IUBMB Life; 2013 Jan; 65(1):76-84. PubMed ID: 23233354
[TBL] [Abstract][Full Text] [Related]
38. Regulatory sharing between estrogen receptor α bound enhancers.
Carleton JB; Ginley-Hidinger M; Berrett KC; Layer RM; Quinlan AR; Gertz J
Nucleic Acids Res; 2020 Jul; 48(12):6597-6610. PubMed ID: 32479598
[TBL] [Abstract][Full Text] [Related]
39. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
[TBL] [Abstract][Full Text] [Related]
40. Allele-Specific Gene Regulation, Phenotypes, and Therapeutic Vulnerabilities in Estrogen Receptor Alpha-Mutant Endometrial Cancer.
Blanchard Z; Rush CM; Arnesen S; Vahrenkamp JM; Rodriguez AC; Jarboe EA; Brown C; Chang MEK; Flory MR; Mohammed H; Modzelewska K; Lum DH; Gertz J
Mol Cancer Res; 2023 Oct; 21(10):1023-1036. PubMed ID: 37363949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
